← Open Payments lookup

LEIGH BETH BROWN: Open Payments

NPI 1689281685 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,606 in 114 payments from 23 companies in 2025. Trend: 2023 $1,737 · 2024 $2,020 · 2025 $2,606

Food & beverage: $2,517Education: $89
CompanyPaymentsAmount
ABBVIE INC.24$326
Janssen Biotech, Inc.12$312
GENZYME CORPORATION11$311
Madrigal Pharmaceuticals8$310
PFIZER INC.6$173
Gilead Sciences, Inc.9$167
Lilly USA, LLC7$150
Enterra Medical, Inc.1$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$118
Takeda Pharmaceuticals U.S.A., Inc.6$118

Products named: DUPIXENT, TREMFYA, REZDIFFRA, VELSIPITY, RINVOQ, OMVOH, XIFAXAN, LINZESS.

Industry payments across MS — which companies pay providers there.